Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Ranging Study of Azilsartan in Essential Hypertension
NCT01289132Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of azilsartan in essential hypertension, sponsored by Takeda. Started Jul 2007; status: completed.
02
Drugs
azilsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01289132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01289132.